Literature DB >> 21596224

Pneumonia risk factors and clinical features of hospitalized patients older than 15 years with pandemic influenza A (H1N1) in South Korea: a multicenter study.

Min Hyok Jeon1, Jin-Won Chung, Seong-Ho Choi, Tae Hyong Kim, Eun Jung Lee, Eun Ju Choo.   

Abstract

While most patients with pandemic influenza A (H1N1) virus had a self-limited disease, some patients had severe pneumonia requiring hospitalization. We conducted a retrospective review to characterize demographically the patients older than 15 years with H1N1 infection requiring hospitalization and assess the risk factors for pneumonia development. The most common underlying medical condition was a respiratory disorder such as asthma or chronic bronchitis (11.4%). The symptoms most common at presentation included fever and cough (91.9% and 71.2%, respectively). Of the 210 patients studied, 55 (26.2%) had viral pneumonia. The independent risk factors for pneumonia were asthma [odds ratio (OR) 4.006], male gender (OR 3.507), and age ≥50 years (OR 2.653). There were insufficient numbers of pregnant, obese, and diabetic patients to allow statistical analyses. Early treatment with antiviral agents was associated with reduced risk of pneumonia (OR 0.822). Our results suggest that asthma, old age, and male gender may be related to pneumonia and that early antiviral treatment may reduce pneumonia risk.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21596224     DOI: 10.1016/j.diagmicrobio.2011.01.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Comparison of viral infection in healthcare-associated pneumonia (HCAP) and community-acquired pneumonia (CAP).

Authors:  Eun Sun Kim; Kyoung Un Park; Sang Hoon Lee; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Choon-Taek Lee; Jae Ho Lee
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

2.  Validation of discharge diagnosis codes to identify serious infections among middle age and older adults.

Authors:  Andrew D Wiese; Marie R Griffin; C Michael Stein; William Schaffner; Robert A Greevy; Edward F Mitchel; Carlos G Grijalva
Journal:  BMJ Open       Date:  2018-06-19       Impact factor: 2.692

3.  Characteristics of hospitalized cases with influenza A (H1N1)pdm09 infection during first winter season of post-pandemic in China.

Authors:  Cuiling Xu; A Danielle Iuliano; Min Chen; Po-Yung Cheng; Tao Chen; Jinghong Shi; Jing Yang; Lijie Wang; Fan Yuan; Marc-Alain Widdowson; Yuelong Shu
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

4.  Influenza-associated mortality in georgia (2009-2011).

Authors:  Maia Butsashvili; George Kandelaki; Khatuna Zakhashvili; Ana Machablishvili; Nata Avaliani
Journal:  Influenza Res Treat       Date:  2012-08-15

5.  Increased Prevalence of H1N1-Induced Severe Lower Respiratory Tract Diseases in Children With Atopic Sensitization.

Authors:  Yun-Ji Kim; Seung-Lok Ryu; Sun-Hee Jung; Jae Won Shim; Deok Soo Kim; Hye Lim Jung; Moon Soo Park; Jung Yeon Shim
Journal:  Allergy Asthma Immunol Res       Date:  2012-05-02       Impact factor: 5.764

6.  Predictors of fatality in pandemic influenza A (H1N1) virus infection among adults.

Authors:  Önder Ergönül; Servet Alan; Öznur Ak; Fatman Sargın; Arzu Kantürk; Alper Gündüz; Derya Engin; Oral Öncül; Ilker Inanc Balkan; Bahadir Ceylan; Nur Benzonana; Saadet Yazıcı; Funda Şimşek; Nuray Uzun; Asuman Inan; Eren Gulhan; Meral Ciblak; Kenan Midilli; Mustafa Ozyurt; Selim Badur; Serap Gencer; Ozcan Nazlıcan; Serdar Özer; Nail Özgüneş; Taner Yıldırmak; Turan Aslan; Pasa Göktaş; Nese Saltoğlu; Muzaffer Fincancı; Ali Ihsan Dokucu; Haluk Eraksoy
Journal:  BMC Infect Dis       Date:  2014-06-10       Impact factor: 3.090

7.  Incidence and Risk Factors of Pneumonia in Hospitalized Patients with Seasonal Influenza A or B.

Authors:  Seongjun Chu; Sang Joon Park; So My Koo; Yang Ki Kim; Ki Up Kim; Soo Taek Uh; Tae Hyung Kim; Suyeon Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-09-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.